ChronoScale Corporation Common Stock (NASDAQ:CHRN) Stock Falls 8.3% – Here’s Why

Shares of ChronoScale Corporation Common Stock (NASDAQ:CHRN) dropped 8.3% on Thursday. The company traded as low as $14.99 and last traded at $15.61. Approximately 144,336 shares changed hands during trading, a decline of 35% from the average session volume of 223,432 shares. The stock had previously closed at $17.02.

Analysts Set New Price Targets

Several research analysts have issued reports on CHRN shares. Northland Securities started coverage on ChronoScale Corporation Common Stock in a report on Friday, September 18th. They set an “outperform” rating and a $32.00 price objective on the stock. Weiss Ratings cut shares of ChronoScale Corporation Common Stock from a “sell (d)” rating to a “sell (d-)” rating in a report on Friday, October 23rd. Finally, Compass Point began coverage on ChronoScale Corporation Common Stock in a research report on Friday, October 16th. They set a “buy” rating and a $25.00 price target on the stock. Two research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $21.00.

ChronoScale Corporation Common Stock Trading Down 7.9%

The business’s 50-day moving average price is $18.62 and its 200 day moving average price is $15.97. The company has a market cap of $2.09 billion, a P/E ratio of -3.33 and a beta of 0.98. The company has a debt-to-equity ratio of 0.02, a quick ratio of 0.30 and a current ratio of 0.30.

ChronoScale Corporation Common Stock (NASDAQ:CHRN) last released its quarterly earnings data on Wednesday, October 14th. The company reported ($0.29) earnings per share (EPS) for the quarter. ChronoScale Corporation Common Stock had a negative net margin of 135.66% and a negative return on equity of 66.16%. The business had revenue of $41.48 million during the quarter. As a group, analysts expect that ChronoScale Corporation Common Stock will post -0.49 earnings per share for the current year.

About ChronoScale Corporation Common Stock

Ekso Bionics Holdings, Inc designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods.